loader
Please Wait
Applying Filters...
FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Genzyme's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client EmailClient Virtual Booth
Filters Filter
×
FILTER DATA :

filter

GENZYME

GENZYME CORP

Genzyme Biopharmaceuticals SA (Pty) Ltd

SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC

filter

AGALSIDASE BETA

ALEMTUZUMAB

ALGLUCOSIDASE ALFA

Alemtuzumab

CLOFARABINE

ELIGLUSTAT (ELIGLUSTAT TARTRATE)

ELIGLUSTAT TARTRATE

FLUDARABINE PHOSPHATE

IMIGLUCERASE

Imiglucerase

LARONIDASE

LEUPROLIDE ACETATE

PLERIXAFOR

SEVELAMER CARBONATE

SEVELAMER HYDROCHLORIDE

Sevelamer Hydrochloride

TERIFLUNOMIDE

THYROTROPIN ALFA

VANDETANIB

filter

CAPSULE

CAPSULE;ORAL

FOR SUSPENSION;ORAL

INF

INJ

INJECTABLE; IV (INFUSION)

INJECTABLE;INJECTION

POWDER FOR SOLUTION

POWDER; IV (INFUSION)

SOLUTION

SOLUTION;INTRAVENOUS

SOLUTION;SUBCUTANEOUS

TAB

TABLET

TABLET;ORAL

VIAL; INTRAVENOUS

filter

0.58MG/ML

0.9MG/VIAL

1.1MG/VIAL

100MG

10MG/ML

10mg/ml

12MG/1.2ML

12MG/1.2ML (10MG/ML)

14MG

1MG/0.2ML

2.4GM/PACKET

200 UNITS/VIAL

200U/5ml

20MG/20ML (1MG/ML)

20MG/KG

24MG/1.2ML (20MG/ML)

300MG

30MG/ML

30mg/ml

35MG/VIAL

400 UNITS/VIAL

400MG

400U/10ml

400UNIT/VIAL

403MG

50MG/VIAL

50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

5MG/ML

5MG/VIAL

800MG

800MG/PACKET

800mg

84MG

EQ 84MG BASE

filter

CANADA

SOUTH AFRICA

USA

VIAL; INTRAVENOUS
5MG/VIAL
FABRAZYME
USA
103979
VIAL; INTRAVENOUS
35MG/VIAL
FABRAZYME
USA
103979
POWDER FOR SOLUTION
5MG/VIAL
FABRAZYME
CANADA
2248965
1.1ML
Prescription
POWDER FOR SOLUTION
35MG/VIAL
FABRAZYME
CANADA
2248966
7.2ML
Prescription
VIAL; INTRAVENOUS
10MG/ML
CAMPATH
USA
103948
VIAL; INTRAVENOUS
30MG/ML
CAMPATH
USA
103948
INJECTABLE;INJECTION
12MG/1.2ML (10MG/ML)
LEMTRADA
USA
103948
SOLUTION
30MG/ML
MABCAMPATH
CANADA
2290960
1ML
Prescription
SOLUTION
12MG/1.2ML
LEMTRADA
CANADA
2418320
1.2ML/VIAL
Prescription
INF
10mg/ml
Mabcampath
SOUTH AFRICA
3X3mg/ml
Originator
INF
30mg/ml
Mabcampath 30 mg/ml
SOUTH AFRICA
1X3mg/ml
Originator
INJECTABLE; IV (INFUSI...
20MG/KG
MYOZYME
USA
125141
POWDER; IV (INFUSION)
5MG/ML
LUMIZYME
USA
125291
POWDER FOR SOLUTION
50MG/VIAL
MYOZYME
CANADA
2284863
10.3ML
Prescription
SOLUTION;INTRAVENOUS
20MG/20ML (1MG/ML)
CLOLAR
USA
21673
2004-12-28
RX
CAPSULE
84MG
CERDELGA
CANADA
2463261
14/56
Prescription
CAPSULE;ORAL
EQ 84MG BASE
CERDELGA
USA
205494
2014-08-19
RX
INJECTABLE;INJECTION
50MG/VIAL **Federal Re...
FLUDARA
USA
20038
1991-04-18
DISCN
INJECTABLE;INJECTION
200 UNITS/VIAL
CEREZYME
USA
20367
INJECTABLE;INJECTION
400 UNITS/VIAL
CEREZYME
USA
20367
POWDER FOR SOLUTION
400UNIT/VIAL
CEREZYME
CANADA
2241751
10.6ML
Prescription
INJ
200U/5ml
Cerezyme 200
SOUTH AFRICA
5X1U/5ml
Originator
INJ
400U/10ml
Cerezyme 400
SOUTH AFRICA
10X1U/10ml
Originator
SOLUTION
0.58MG/ML
ALDURAZYME
CANADA
2254506
5.3ML
Prescription
INJECTABLE;INJECTION
1MG/0.2ML
LEUPROLIDE ACETATE
USA
75721
2001-11-29
DISCN
SOLUTION;SUBCUTANEOUS
24MG/1.2ML (20MG/ML)
MOZOBIL
USA
22311
2008-12-15
RX
FOR SUSPENSION;ORAL
800MG/PACKET
RENVELA
USA
22318
2009-08-12
RX
FOR SUSPENSION;ORAL
2.4GM/PACKET
RENVELA
USA
22318
2009-02-18
RX
CAPSULE;ORAL
403MG
RENAGEL
USA
20926
1998-10-30
DISCN
TABLET;ORAL
400MG
RENAGEL
USA
21179
2000-07-12
RX
TABLET;ORAL
800MG
RENAGEL
USA
21179
2000-07-12
RX
TAB
800mg
Renagel
SOUTH AFRICA
180X1mg
Originator
TABLET
14MG
AUBAGIO
CANADA
2416328
28
Prescription
INJECTABLE;INJECTION
1.1MG/VIAL
THYROGEN
USA
20898
POWDER FOR SOLUTION
0.9MG/VIAL
THYROGEN
CANADA
2246016
1.2 ML
Prescription
TABLET;ORAL
100MG
CAPRELSA
USA
22405
2011-04-06
RX
TABLET;ORAL
300MG
CAPRELSA
USA
22405
2011-04-06
RX
TABLET
100MG
CAPRELSA
CANADA
2378582
30
Prescription
TABLET
300MG
CAPRELSA
CANADA
2378590
30
Prescription

PharmaCompass >>

First
Previous
Next
Last